Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W Geisbert

Showing results (1-10 of 279) with videos related to

Pageof 28
Sort By:
Nature|August 30, 2014
Medical research: Ebola therapy protects severely ill monkeysThomas W Geisbert
JAMA|March 6, 2015
Emergency treatment for exposure to Ebola virus: the need to fast-track promising vaccinesThomas W Geisbert
The Lancet. Global Health|December 14, 2016
Persistence of Ebola virus RNA in seminal fluidThomas W Geisbert
Lancet (London, England)|December 27, 2016
First Ebola virus vaccine to protect human beings?Thomas W Geisbert
The Lancet. Infectious Diseases|March 11, 2018
Predicting outcome and improving treatment for Lassa feverThomas W Geisbert
Current Molecular Medicine|December 27, 2005
Emerging viruses: advances and challengesThomas W Geisbert
Plos Pathogens|December 9, 2021
Current state of Ebola virus vaccines: A snapshotCourtney Woolsey, Thomas W Geisbert
Nature|January 28, 2021
Antibodies periodically wax and wane in survivors of EbolaCourtney Woolsey, Thomas W Geisbert
Clinical Microbiology Reviews|June 15, 2026
Marburg virus disease: a comprehensive reviewCourtney Woolsey, Thomas W Geisbert
The Journal of Infectious Diseases|October 12, 2011
Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infectionsThomas W Geisbert, Heinz Feldmann
Pageof 28

Showing results (1-10 of 279) with videos related to

Sort By:
Pageof 28
Nature|August 30, 2014
Medical research: Ebola therapy protects severely ill monkeysThomas W Geisbert
JAMA|March 6, 2015
Emergency treatment for exposure to Ebola virus: the need to fast-track promising vaccinesThomas W Geisbert
The Lancet. Global Health|December 14, 2016
Persistence of Ebola virus RNA in seminal fluidThomas W Geisbert
Lancet (London, England)|December 27, 2016
First Ebola virus vaccine to protect human beings?Thomas W Geisbert
The Lancet. Infectious Diseases|March 11, 2018
Predicting outcome and improving treatment for Lassa feverThomas W Geisbert
Current Molecular Medicine|December 27, 2005
Emerging viruses: advances and challengesThomas W Geisbert
Plos Pathogens|December 9, 2021
Current state of Ebola virus vaccines: A snapshotCourtney Woolsey, Thomas W Geisbert
Nature|January 28, 2021
Antibodies periodically wax and wane in survivors of EbolaCourtney Woolsey, Thomas W Geisbert
Clinical Microbiology Reviews|June 15, 2026
Marburg virus disease: a comprehensive reviewCourtney Woolsey, Thomas W Geisbert
The Journal of Infectious Diseases|October 12, 2011
Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infectionsThomas W Geisbert, Heinz Feldmann
Pageof 28